晚期胃癌-话题@MedSci

#晚期胃癌#

96篇内容 | 4093人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276603, encodeId=2ca212e660350, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=盘点晚期胃癌免疫一线治疗新进展, objectType=article, longId=168879, objectId=c7fa1688e986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7fa1688e986, replyNumber=0, likeNumber=60, createdTime=2019-06-22, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7fa1688e986, moduleTitle=盘点晚期胃癌免疫一线治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7fa1688e986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276602, encodeId=0c8c12e660260, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=晚期胃癌中国研究，为胃癌治疗提供新治疗方案, objectType=article, longId=168242, objectId=c3001682422e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3001682422e, replyNumber=0, likeNumber=82, createdTime=2019-06-14, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3001682422e, moduleTitle=晚期胃癌中国研究，为胃癌治疗提供新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3001682422e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276601, encodeId=26a412e66014d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优, objectType=article, longId=168155, objectId=2445168155ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2445168155ce, replyNumber=0, likeNumber=59, createdTime=2019-06-13, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2445168155ce, moduleTitle=FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2445168155ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276600, encodeId=a07312e6600d6, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=纳武利尤单抗治疗晚期胃癌新进展, objectType=article, longId=167954, objectId=54e816e95456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54e816e95456, replyNumber=0, likeNumber=157, createdTime=2019-06-11, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54e816e95456, moduleTitle=纳武利尤单抗治疗晚期胃癌新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54e816e95456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276599, encodeId=c14212e6599a2, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=帕博利珠单抗或为晚期胃癌一线治疗提供新选择, objectType=article, longId=167950, objectId=1d9b16e95039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d9b16e95039, replyNumber=0, likeNumber=75, createdTime=2019-06-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d9b16e95039, moduleTitle=帕博利珠单抗或为晚期胃癌一线治疗提供新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d9b16e95039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276598, encodeId=84ed12e659840, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=瑞戈非尼联合纳武利尤单抗治疗MSS型晚期胃癌和结直肠癌柳暗花明新征程, objectType=article, longId=167947, objectId=bbd416e947e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbd416e947e3, replyNumber=0, likeNumber=78, createdTime=2019-06-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbd416e947e3, moduleTitle=瑞戈非尼联合纳武利尤单抗治疗MSS型晚期胃癌和结直肠癌柳暗花明新征程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbd416e947e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276597, encodeId=d4bd12e6597dd, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet oncol：三氟尿苷/替匹拉齐可明显提高晚期胃癌患者的总体存活期, objectType=article, longId=152063, objectId=5e8015206345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e8015206345, replyNumber=0, likeNumber=71, createdTime=2018-10-29, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e8015206345, moduleTitle=Lancet oncol：三氟尿苷/替匹拉齐可明显提高晚期胃癌患者的总体存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e8015206345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276596, encodeId=201a12e65968e, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Ann Oncol：口服紫杉醇二线治疗晚期胃癌是否有效？, objectType=article, longId=140231, objectId=0bac1402313a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bac1402313a, replyNumber=0, likeNumber=65, createdTime=2018-06-09, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bac1402313a, moduleTitle=Ann Oncol：口服紫杉醇二线治疗晚期胃癌是否有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bac1402313a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276595, encodeId=7a8f12e65952e, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=ANN ONCOL：口服和静脉紫杉醇对一线治疗失败的晚期胃癌治疗效果比较, objectType=article, longId=140188, objectId=411b140188fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411b140188fd, replyNumber=0, likeNumber=65, createdTime=2018-06-08, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411b140188fd, moduleTitle=ANN ONCOL：口服和静脉紫杉醇对一线治疗失败的晚期胃癌治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411b140188fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276594, encodeId=823e12e659468, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Gastroen Hepatol：口服氟嘧啶与静脉5-氟尿嘧啶治疗晚期胃癌和结直肠癌, objectType=article, longId=129559, objectId=b94f12955988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94f12955988, replyNumber=0, likeNumber=63, createdTime=2018-02-12, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94f12955988, moduleTitle=J Gastroen Hepatol：口服氟嘧啶与静脉5-氟尿嘧啶治疗晚期胃癌和结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b94f12955988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276593, encodeId=a0e712e6593ad, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=这位晚期胃癌患者生存超过了10年, objectType=article, longId=126953, objectId=819d1269535e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=819d1269535e, replyNumber=0, likeNumber=48, createdTime=2018-01-21, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=819d1269535e, moduleTitle=这位晚期胃癌患者生存超过了10年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=819d1269535e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276592, encodeId=475612e6592a2, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet Oncol：奥拉帕尼+紫杉醇亚洲晚期胃癌患者的理想选择？, objectType=article, longId=125694, objectId=45f5125694ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45f5125694ca, replyNumber=0, likeNumber=76, createdTime=2018-01-07, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45f5125694ca, moduleTitle=Lancet Oncol：奥拉帕尼+紫杉醇亚洲晚期胃癌患者的理想选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45f5125694ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276591, encodeId=7cc112e659117, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet ONCOL：奥拉帕尼联合紫杉醇治疗一线治疗后进展的晚期胃癌患者, objectType=article, longId=119081, objectId=b0e911908184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0e911908184, replyNumber=0, likeNumber=72, createdTime=2017-11-09, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0e911908184, moduleTitle=Lancet ONCOL：奥拉帕尼联合紫杉醇治疗一线治疗后进展的晚期胃癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0e911908184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276590, encodeId=d8ab12e6590ad, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Gastroen Hepatol：新药雷莫芦单抗（Ramucirumab）治疗晚期胃癌有奇效！, objectType=article, longId=117546, objectId=4e5d11e5460b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e5d11e5460b, replyNumber=0, likeNumber=56, createdTime=2017-10-27, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e5d11e5460b, moduleTitle=J Gastroen Hepatol：新药雷莫芦单抗（Ramucirumab）治疗晚期胃癌有奇效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e5d11e5460b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276589, encodeId=54c712e6589a6, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, objectType=article, longId=116277, objectId=b63e1162e77c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b63e1162e77c, replyNumber=0, likeNumber=65, createdTime=2017-10-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b63e1162e77c, moduleTitle=Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b63e1162e77c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276588, encodeId=e23612e658881, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月, objectType=article, longId=114765, objectId=fa54114e6577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa54114e6577, replyNumber=0, likeNumber=67, createdTime=2017-09-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa54114e6577, moduleTitle=【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa54114e6577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276587, encodeId=3fb012e65876d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率, objectType=article, longId=93205, objectId=fef993205fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef993205fc, replyNumber=0, likeNumber=33, createdTime=2017-03-25, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef993205fc, moduleTitle=The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef993205fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276586, encodeId=c25412e6586f0, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=2016HER2阳性晚期胃癌分子靶向治疗的中国专家共识发布, objectType=article, longId=80314, objectId=1cdf80314fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cdf80314fa, replyNumber=0, likeNumber=37, createdTime=2016-10-20, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cdf80314fa, moduleTitle=2016HER2阳性晚期胃癌分子靶向治疗的中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cdf80314fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276585, encodeId=1e8712e658596, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Clin Cancer Res：PET能用于预测晚期胃癌患者的化疗反应, objectType=article, longId=60053, objectId=ced260053f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced260053f2, replyNumber=0, likeNumber=55, createdTime=2015-12-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced260053f2, moduleTitle=Clin Cancer Res：PET能用于预测晚期胃癌患者的化疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced260053f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276584, encodeId=608a12e65846c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：HER2，EGFR及c-Met状态对晚期胃癌患者总存活的预后影响, objectType=article, longId=47688, objectId=9d5b4e68878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d5b4e68878, replyNumber=0, likeNumber=86, createdTime=2015-03-05, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d5b4e68878, moduleTitle=Gastric Cancer：HER2，EGFR及c-Met状态对晚期胃癌患者总存活的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d5b4e68878)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胃癌

2020-05-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

盘点晚期胃癌免疫一线治疗新进展

2019-06-22

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

晚期胃癌中国研究，为胃癌治疗提供新治疗方案

2019-06-14

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

FTD（TAS-102）后线治疗晚期胃癌疗效与安全性并优

2019-06-13

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

纳武利尤单抗治疗晚期胃癌新进展

2019-06-11

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

帕博利珠单抗或为晚期胃癌一线治疗提供新选择

2019-06-11

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

瑞戈非尼联合纳武利尤单抗治疗MSS型晚期胃癌和结直肠癌柳暗花明新征程

2019-06-11

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet oncol：三氟尿苷/替匹拉齐可明显提高晚期胃癌患者的总体存活期

2018-10-29

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Ann Oncol：口服紫杉醇二线治疗晚期胃癌是否有效？

2018-06-09

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

ANN ONCOL：口服和静脉紫杉醇对一线治疗失败的晚期胃癌治疗效果比较

2018-06-08

智智灵药 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Gastroen Hepatol：口服氟嘧啶与静脉5-氟尿嘧啶治疗晚期胃癌和结直肠癌

2018-02-12

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

这位晚期胃癌患者生存超过了10年

2018-01-21

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet Oncol：奥拉帕尼+紫杉醇亚洲晚期胃癌患者的理想选择？

2018-01-07

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet ONCOL：奥拉帕尼联合紫杉醇治疗一线治疗后进展的晚期胃癌患者

2017-11-09

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Gastroen Hepatol：新药雷莫芦单抗（Ramucirumab）治疗晚期胃癌有奇效！

2017-10-27

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet：Nivolumab为晚期胃癌或胃-食管结合部肿瘤患者带来生存获益

2017-10-17

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月

2017-09-30

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率

2017-03-25

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

2016HER2阳性晚期胃癌分子靶向治疗的中国专家共识发布

2016-10-20

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Clin Cancer Res：PET能用于预测晚期胃癌患者的化疗反应

2015-12-04

柳叶一刀 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：HER2，EGFR及c-Met状态对晚期胃癌患者总存活的预后影响

2015-03-05

科室
- - 订阅+
  - 更多科室
工具
服务